Biovac Ltd

Industry

CEA & horticulture, Crop protection, Fishery & aquaculture, Food ingredients, Veterinary

Topics

Vitamins, carotenoids & nutraceutical actives, Crop protection chemicals & fertilizers, Animal & aquaculture vaccines, Vertical farming & controlled-environment agriculture

Role

Producer — “…the research, development, manufacturing, and distribution of veterinary vaccines, pharmaceuticals, vitamins,…”

Parent / group

Biovac Group

Why it is bioeconomy

Biovac Ltd. is a veterinary company engaged in the R&D, manufacture, and distribution of animal vaccines, pharmaceuticals, and biological solutions for livestock.

Found via

[Rubric] Israel · animal-vaccines; [Rubric] Israel · phages

Not yet cited as a supplier in a graded solution.

Subsidiaries: Biovac Biological and Pharmaceutical Laboratories

• 2026-07-27 AfDB provides $15m to Biovac for new multi-vaccine production facility
  Biovac Ltd is expanding into Africa’s first end-to-end oral cholera vaccine production and local inactivated polio vaccine manufacturing, backed by a $15 million AfDB loan to build a new multi-vaccine facility in Cape Town, boosting domestic vaccine capacity …
• 2026-05-13 EXCLUSIVE | Biovac secures crucial R5.3bn state vaccine contract
  Biovac Ltd secured a crucial R5.3 billion three-year vaccine contract to supply Hexaxim and won additional contracts for BCG and measles-rubella, strengthening its financial stability after past losses and offsetting reliance on state work.
• 2026-04-20 Biovac nets $108M finance package for integrated vaccine plant
  Biovac Ltd. has secured a $108.3 million financing package to build Africa’s first end-to-end, multi-vaccine production plant in Cape Town, aiming to produce up to 40 million doses annually and significantly expand local vaccine manufacturing and skills …
• 2026-04-17 Biovac gets European backing for vaccine facility in Africa | Pharma Manufacturing
  Biovac Ltd. is securing European-backed funding to build Africa’s first end-to-end multi-vaccine manufacturing facility, with capacity of 30–40 million doses per year, aimed at local production, technology transfer, and job creation (over 340 skilled …
• 2026-04-21 Biovac end-to-end vaccine manufacturing facility gets financial backing
  Biovac Ltd. is securing major international financing to build Africa’s first end-to-end multi-vaccine manufacturing facility in South Africa, with initial output of oral cholera vaccine and future expansion to polio, pneumonia, and meningitis vaccines, …
• 2026-07-27 AfDB invests US$15M in Biovac to advance African vaccine manufacturing sovereignty | HealthCare Middle East & Africa - No.1 Health & Pharma Manufacturing Industry Publication
  Biovac Ltd is a South Africa-based vaccine manufacturer expanding into an end-to-end, multi-vaccine facility in Cape Town with AfDB financing to boost Africa’s local vaccine production capacity to up to 500 million doses annually, create about 340 jobs, and …

Ownership & investors 2

Similar companies

MEVAC for Vaccines · Vaccine Valley · MCI Santé Animale · Intermedicavet - IMV · International Free Trade Corporation - IFT · MEDMAC · MAS · CHEMVETJO